State of Alaska, Department of Revenue - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 222 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
State of Alaska, Department of Revenue ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$937
-13.0%
33,991
-5.2%
0.01%
-7.7%
Q2 2023$1,077
-19.7%
35,844
-3.2%
0.01%
-18.8%
Q1 2023$1,341
-0.1%
37,018
-1.7%
0.02%
-5.9%
Q4 2022$1,342
-99.9%
37,642
+1.5%
0.02%0.0%
Q3 2022$1,254,000
+7.4%
37,070
-8.2%
0.02%
+21.4%
Q2 2022$1,168,000
-2.3%
40,401
+9.2%
0.01%
+7.7%
Q1 2022$1,195,000
+8.8%
36,996
-1.8%
0.01%
+18.2%
Q4 2021$1,098,000
+6.2%
37,656
-2.9%
0.01%
+10.0%
Q3 2021$1,034,000
-8.4%
38,771
+5.7%
0.01%
-9.1%
Q2 2021$1,129,000
+20.5%
36,694
+2.4%
0.01%
+10.0%
Q1 2021$937,000
-9.1%
35,824
-12.6%
0.01%
-16.7%
Q4 2020$1,031,000
+0.5%
41,004
-16.8%
0.01%
-7.7%
Q3 2020$1,026,000
-12.8%
49,272
-0.6%
0.01%
-13.3%
Q2 2020$1,177,000
+40.6%
49,562
+6.5%
0.02%
+15.4%
Q1 2020$837,000
-10.9%
46,552
+17.5%
0.01%
+8.3%
Q4 2019$939,000
-15.2%
39,617
-1.7%
0.01%
-20.0%
Q3 2019$1,107,000
+87.6%
40,292
+126.0%
0.02%
+50.0%
Q2 2019$590,000
-4.4%
17,831
+1.1%
0.01%
-9.1%
Q1 2019$617,000
+6.2%
17,636
+0.7%
0.01%0.0%
Q4 2018$581,000
-32.3%
17,506
+2.6%
0.01%
-21.4%
Q3 2018$858,000
-15.3%
17,059
+0.7%
0.01%
-22.2%
Q2 2018$1,013,000
+32.9%
16,939
+1.8%
0.02%
+12.5%
Q1 2018$762,000
+87.7%
16,639
+63.0%
0.02%
+60.0%
Q4 2017$406,000
+2.0%
10,209
+2.4%
0.01%
-50.0%
Q3 2017$398,000
-6.8%
9,969
+0.4%
0.02%
-31.0%
Q2 2017$427,000
+146.8%
9,929
+79.5%
0.03%
+123.1%
Q1 2017$173,000
+28.1%
5,530
+3.2%
0.01%0.0%
Q4 2016$135,0005,3600.01%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders